Rx Medicare

Neuralieve, a medical technology company pioneering a new approach to treat migraine headache, reported positive data on the mechanism of action of TMS technology for the treatment of migraine aura. The results will be presented during the annual American Academy of Neurology (AAN) Scientific Meeting in Seattle by Peter J. Goadsby, MD, PhD, Professor and Director of the Headache Program at the University of California, San Francisco.

Read More…

Related Posts

• Migraine With Aura: Magnetic Stimulation Is A Promising Non-Drug Treatment Option
• Promise For Non-Drug Treatment Of Migraine From New Therapy Based On Magnetic Stimulation
• NanoViricides Presents FluCide™ Animal Study Data At Influenza Congress – Now Improved Substantially And Vastly Superior To Current Treatment
• Migraine With Aura Is Associated With Increased Risk Of Stroke
• Migraine With Aura Doubles The Risk Of Stroke
• Migraine Patients Who Experience Aura May Have A Two-Fold Increased Risk For Ischemic Stroke
• Cocoa Enriched Diets May Be Beneficial In Treatment Of Migraine
• Mylan Receives FDA Approval For Generic Version Of Migraine Treatment Imitrex(R)
• Locust Study Points Toward New Treatment For Stroke And Migraine
• Midlife Migraine With Aura Linked To Brain Lesions In Later Life
• Know about Migraine Treatment Posted By : Peter Hutch
• Patent Foramen Ovale Closure Extremely Promising For Stroke Prevention And Treatment Of Migraine
• Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
• Alkermes Announces Initiation Of Multidose Phase 1 Clinical Study Of ALKS 37 For The Treatment Of Opioid-Induced Constipation
• Breakthroughs In Treatment Of Spine And Back Conditions

Tags: aura, data, magnetic, migraine, neuralieve, stimulation, transcranial, treatment

This entry was posted on Wednesday, May 6th, 2009 at 1:05 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.